The FDA has approved an autism evaluation tool for children 16 to 30 months old. Developed by EarliTec Diagnostics, EarliPoint Evaluation uses eye-tracking technology on a portable tablet.
The system measures more than 120 focal preferences per second and determines if a child misses critical moments of social learning.
Why it matters
Early diagnosis is crucial in supporting children with autism to develop essential language, communication, social, and cognitive skills.
The takeaway
Earlipoint Evaluation aims to provide earlier autism diagnosis during the critical developmental window when interventions can have the most impact.
Although the prevalence of autism is growing, our health care system is missing a critical developmental window for children. Our goal is to help parents and care providers access earlier autism diagnosis during the life stage when interventions can be most impactful. —Tom Ressemann, CEO EarliTec Diagnostics
